Ghada Malik

Publications by Year

Research Areas

Neuroblastoma Research and Treatments, Retinoids in leukemia and cellular processes, Drug-Induced Ocular Toxicity, Cancer therapeutics and mechanisms, Cell Adhesion Molecules Research

Most-Cited Works

• → A Non-Glycosaminoglycan-Binding Variant of CC Chemokine Ligand 7 (Monocyte Chemoattractant Protein-3) Antagonizes Chemokine-Mediated Inflammation(2005)74 cited
• → Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma(2016)61 cited
• → Adaptive Dosing Approaches to the Individualization of 13- Cis -Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma(2012)53 cited
• → Characterisation of the Clinical Pharmacokinetics of Actinomycin D and the Influence of ABCB1 Pharmacogenetic Variation on Actinomycin D Disposition in Children with Cancer(2014)44 cited
• → Renal Transplantation: Examination of the Regulation of Chemokine Binding During Acute Rejection(2005)23 cited
• → Investigating the Experiences of Childhood Cancer Patients and Parents Participating in Optional Nontherapeutic Clinical Research Studies in the UK(2016)7 cited
• → Supplementary Figure 2 from Adaptive Dosing Approaches to the Individualization of 13-<i>Cis</i>-Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma(2023)
• → Supplementary Figure 1 from Adaptive Dosing Approaches to the Individualization of 13-<i>Cis</i>-Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma(2023)
• → Supplementary Figure Legend from Adaptive Dosing Approaches to the Individualization of 13-<i>Cis</i>-Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma(2023)